2023
Chronic Kidney Disease Management in the Middle East and Africa: Concerns, Challenges, and Novel Approaches
Al-Ghamdi S, Abu-Alfa A, Alotaibi T, AlSaaidi A, AlSuwaida A, Arici M, Ecder T, Koraie A, Ghnaimat M, Hafez M, Hassan M, Sqalli T. Chronic Kidney Disease Management in the Middle East and Africa: Concerns, Challenges, and Novel Approaches. International Journal Of Nephrology And Renovascular Disease 2023, 16: 103-112. PMID: 37051319, PMCID: PMC10084934, DOI: 10.2147/ijnrd.s363133.Peer-Reviewed Original ResearchChronic kidney diseaseManagement of CKDChronic kidney disease managementKidney disease managementManagement of patientsNovel therapeutic optionsTherapeutic optionsKidney diseaseProtective therapyOverall burdenEarly diagnosisAvailable evidenceDisease managementHealthcare specialistsHealthcare systemHealthcare policyPatientsSteering CommitteeBurdenRiskHypertensionComorbiditiesDiabetesReferralTherapy
2020
Framework for establishing integrated kidney care programs in low- and middle-income countries
Tonelli M, Nkunu V, Varghese C, Abu-Alfa AK, Alrukhaimi MN, Bernieh B, Fox L, Gill J, Harris D, Hou F, O’Connell P, Rashid H, Niang A, Ossareh S, Tesar V, Zakharova E, Yang C. Framework for establishing integrated kidney care programs in low- and middle-income countries. Kidney International Supplements 2020, 10: e19-e23. PMID: 32149006, PMCID: PMC7031683, DOI: 10.1016/j.kisu.2019.11.002.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsChronic kidney diseaseKidney care programKidney replacement therapyKidney failureKidney diseaseKidney careMiddle-income countriesReplacement therapyCare programAcute kidney injuryUrgent public health needPublic health needsKidney injuryKidney transplantationPrimary preventionPreventive careRisk factorsNoncommunicable diseasesTimely managementKidney disordersHealth needsMild formHealth systemDiseaseTherapy
2009
Successful Use of Intraperitoneal Daptomycin in the Treatment of Vancomycin-Resistant Enterococcus Peritonitis
Huen SC, Hall I, Topal J, Mahnensmith RL, Brewster UC, Abu-Alfa AK. Successful Use of Intraperitoneal Daptomycin in the Treatment of Vancomycin-Resistant Enterococcus Peritonitis. American Journal Of Kidney Diseases 2009, 54: 538-541. PMID: 19237231, DOI: 10.1053/j.ajkd.2008.12.017.Peer-Reviewed Case Reports and Technical NotesConceptsIntraperitoneal daptomycinPeritoneal dialysis-associated peritonitisDialysis-associated peritonitisEnterococcus faecium peritonitisSuch resistant organismsPeritoneal dialysis therapyTreatment of patientsVancomycin-resistant enterococciDialysis therapyDialysate exchangePeritonitisResistant organismsPatientsDaptomycinDextrose solutionAdditional studiesTreatmentSuccessful useRelapseDosingTherapyPharmacokineticsInfection
2003
Addition of sertraline to other therapies to reduce dialysis‐associated hypotension
BREWSTER UC, CIAMPI MA, ABU‐ALFA A, PERAZELLA MA. Addition of sertraline to other therapies to reduce dialysis‐associated hypotension. Nephrology 2003, 8: 296-301. PMID: 15012700, DOI: 10.1111/j.1440-1797.2003.00216.x.Peer-Reviewed Original ResearchConceptsDialysis-associated hypotensionCentral blood volumePeripheral vascular resistanceBlood pressureCardiac outputBlood volumeEnd-stage renal disease patientsInitiation of dialysisRenal disease patientsDiastolic blood pressureSystolic blood pressureEffects of sertralineTermination of dialysisAddition of sertralineUltrasound dilution techniqueVascular resistanceArterial pressureHaemodynamic measurementsDisease patientsPatientsControl phaseSertralineTherapyDialysisHypotension